Risk and outcome of COVID-19 infection in sarcoidosis patients:results of a self-reporting questionnaire
- Baughman, Robert P.
- Lower, Elyse E.
- Buchanan, Mindy
- Rottoli, Paola
- Drent, Marjolein
- Sellares, Jacobo
- Terwiel, Michelle
- Elfferich, Marjon
- Francesqui, Joel
- Barriuso Cabrerizo, Maria Rita
- Sweiss, Nadera
- Martone, Filippo
- Al-Hakim, Tamara
- Judson, Marc A.
Publication date
January 2020
DOIAbstract
Background: It has been suggested that sarcoidosis patients, especially those on immunosuppressive medications, are at increased risk for COVID-19 infection and more severe disease. Methods: A questionnaire was developed in four languages (English, Dutch, Italian, and Spanish). The questionnaire queried whether patients had been infected with COVID-19 and outcome of the infection. Risk factors for COVID-19 infection were collected. Results: A total of 5200 sarcoidosis patients completed the questionnaire with 116 (2.23%) reporting infection and 18 (15.8%) required hospitalization. Increased hazard ratio (HR) for COVID-19 infection were seen for those with a COVID-19 infected roommate (HR=27.44, p</p
Add to ORKG